Xenetic Biosciences Inc. (XBIOW)
17.54
-5.40 (-23.54%)
At close: Jul 16, 2024, 8:00 PM
-23.54% (1D)
| Bid | n/a |
| Market Cap | 3.7M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -3.96M |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 2 |
| Avg. Volume (20D) | 635 |
| Open | 16.70 |
| Previous Close | 22.94 |
| Day's Range | 16.70 - 17.54 |
| 52-Week Range | 1.02 - 20.50 |
| Beta | 2.30 |
About XBIOW
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 23, 2019
Employees 4
Stock Exchange NASDAQ
Ticker Symbol XBIOW